PTNTD Stock Price, News & Analysis

PTNTD is the trading symbol used for shares of Palatin Technologies, Inc. in connection with the company’s listing and capital markets activity described in its U.S. Securities and Exchange Commission (SEC) filings. Palatin Technologies, Inc. is a Delaware corporation, as stated in multiple SEC reports, and its common stock has traded under different symbols on various markets over time, including references to "PTN" and "PTNT" in the filings. The PTNTD symbol is associated with this same corporate issuer for investors reviewing historical or symbol-specific stock information.

According to the company’s registration statement on Form S-1/A and current reports on Form 8-K, Palatin Technologies, Inc. has used public offerings of common stock and warrants as part of its financing activities. These filings describe firm commitment public offerings of common stock together with Series J and Series K common stock purchase warrants, as well as pre-funded warrants and underwriter warrants. The documents also explain how these securities are structured, including combined public offering prices, warrant exercise prices, and conditions related to warrant terms.

Palatin Technologies, Inc. reports that it is incorporated in Delaware and identifies a primary Standard Industrial Classification (SIC) code of 2834 in its S-1/A filing. The company’s SEC filings note that it has been listed on the NYSE American under the symbol "PTN" and that its common stock has also traded on the OTC Markets Group under the symbol "PTNT" following a suspension of trading on the NYSE American. The filings further describe a reverse stock split of the company’s outstanding shares of common stock at a ratio of one-for-fifty, which is relevant context for understanding historical share and price information tied to symbols associated with the company.

In addition to equity offerings, the company’s 8-K filings describe an underwriting agreement with A.G.P./Alliance Global Partners and Laidlaw & Company (UK) Ltd. for a public offering of common stock (or pre-funded warrants in lieu thereof) together with Series J and Series K warrants. The filings outline the terms of these securities, including the exercise periods, exercise prices, and conditions under which certain warrants may terminate. They also reference the role of underwriters and the presence of underwriter warrants.

The SEC reports further discuss Palatin Technologies, Inc.’s interactions with the NYSE American listing standards. The company received a notice from NYSE American stating that its common stock was no longer considered suitable for listing under Section 1003(f)(v) of the NYSE American Company Guide due to a low selling price, and that delisting proceedings were commenced. Trading of the company’s common stock on NYSE American was suspended on May 7, 2025, after which the stock traded on OTC markets under the symbol "PTNT." Subsequent filings describe steps taken by the company, including a reverse stock split and equity offerings, to regain compliance with NYSE American continued listing standards, and note that, effective November 12, 2025, the company’s common stock was expected to resume trading on the NYSE American exchange under the symbol "PTN."

Palatin Technologies, Inc. also reports in its 8-K filings that it entered into a business development collaboration agreement with Boehringer Ingelheim International GmbH. The company’s disclosure indicates that this agreement includes upfront and milestone payments, with a specified research milestone achievement triggering a payment to Palatin. The filings describe the potential for additional near-term research milestones, success-based development, regulatory and commercial milestone payments, and tiered royalties on net sales resulting from the collaboration, as outlined in the agreement.

Overall, the PTNTD symbol is linked to the equity of Palatin Technologies, Inc. as documented in SEC filings that detail its corporate jurisdiction, securities offerings, listing status, and certain collaboration arrangements. Investors analyzing PTNTD-related information typically review these filings to understand the structure of the company’s securities, historical trading venues and symbols, and key corporate events affecting the stock.